Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Nasdaq Biotechnology

109.80
-0.6684-0.61%
Post-market: 109.76-0.0402-0.04%19:30 EDT
Volume:10.03K
Turnover:1.10M
Market Cap:92.23M
PE:- -
High:111.43
Open:111.43
Low:108.92
Close:110.47
52wk High:126.40
52wk Low:62.72
Shares:840.00K
Float Shares:840.00K
Volume Ratio:1.58
T/O Rate:1.19%
Dividend:0.22
Dividend Rate:0.20%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 18

Moderna Inc. Stock Climbs 8.5%, Outperforms Peers

Dow Jones
·
Sep 18

Amgen Targets First-Line ITP Market With New Phase 3 Romiplostim Trial

TIPRANKS
·
Sep 18

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)

TIPRANKS
·
Sep 17

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Atricure (ATRC) and Stryker (SYK)

TIPRANKS
·
Sep 17

Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing

Dow Jones
·
Sep 17

Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock

Reuters
·
Sep 17

Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention

THOMSON REUTERS
·
Sep 16

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)

TIPRANKS
·
Sep 16

The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.

Dow Jones
·
Sep 16

Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug

Reuters
·
Sep 16

Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers

Reuters
·
Sep 16

Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar

Reuters
·
Sep 16

Gilead Sciences Expands Lenacapavir Access to 14 Countries

MT Newswires Live
·
Sep 15

Gilead announces agreement with PAHO for lenacapavir access

TIPRANKS
·
Sep 15

Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir

THOMSON REUTERS
·
Sep 15

Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds

THOMSON REUTERS
·
Sep 15

Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean

THOMSON REUTERS
·
Sep 15

Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America, Caribbean

Reuters
·
Sep 15

Gilead: to Continue Exploring Opportunities to Work with Paho to Support Country Readiness & Scale-up of Long-Acting Hiv Prevention Access

THOMSON REUTERS
·
Sep 15